ZA972990B - Isatin derivatives as acetylcholinesterase inhibitors and analgesics. - Google Patents
Isatin derivatives as acetylcholinesterase inhibitors and analgesics.Info
- Publication number
- ZA972990B ZA972990B ZA9702990A ZA972990A ZA972990B ZA 972990 B ZA972990 B ZA 972990B ZA 9702990 A ZA9702990 A ZA 9702990A ZA 972990 A ZA972990 A ZA 972990A ZA 972990 B ZA972990 B ZA 972990B
- Authority
- ZA
- South Africa
- Prior art keywords
- analgesics
- acetylcholinesterase inhibitors
- isatin derivatives
- isatin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63187096A | 1996-04-12 | 1996-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA972990B true ZA972990B (en) | 1997-11-03 |
Family
ID=24533114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9702990A ZA972990B (en) | 1996-04-12 | 1997-04-08 | Isatin derivatives as acetylcholinesterase inhibitors and analgesics. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0892796B1 (ja) |
| JP (1) | JP4109718B2 (ja) |
| KR (1) | KR20000005379A (ja) |
| CN (1) | CN1215399A (ja) |
| AR (1) | AR006606A1 (ja) |
| AT (1) | ATE207483T1 (ja) |
| BR (1) | BR9708655A (ja) |
| CA (1) | CA2252039C (ja) |
| DE (1) | DE69707659T2 (ja) |
| DK (1) | DK0892796T3 (ja) |
| ES (1) | ES2165586T3 (ja) |
| GR (1) | GR3037006T3 (ja) |
| HU (1) | HUP9903473A3 (ja) |
| IL (1) | IL126308A0 (ja) |
| NO (1) | NO984740D0 (ja) |
| PT (1) | PT892796E (ja) |
| TW (1) | TW426678B (ja) |
| WO (1) | WO1997038993A1 (ja) |
| ZA (1) | ZA972990B (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| JP5523107B2 (ja) | 2006-11-30 | 2014-06-18 | プロビオドルグ エージー | グルタミニルシクラーゼの新規阻害剤 |
| ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| ES2533484T3 (es) | 2007-04-18 | 2015-04-10 | Probiodrug Ag | Derivados de tiourea como inhibidores de la glutaminil ciclasa |
| EA022007B1 (ru) | 2009-09-11 | 2015-10-30 | Пробиодруг Аг | Гетероциклические производные в качестве ингибиторов глутаминилциклазы |
| JP6082250B2 (ja) | 2010-02-09 | 2017-02-15 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 認知機能を改善するための方法および組成物 |
| CN102762554A (zh) | 2010-02-16 | 2012-10-31 | 辉瑞大药厂 | 5-ht4受体的部分激动剂(r)-4-((4-((4-(四氢呋喃-3-基氧基)苯并[d]异*唑-3-基氧基)甲基)哌啶-1-基)甲基)四氢-2h-吡喃-4-醇 |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| KR101790806B1 (ko) | 2010-03-10 | 2017-11-20 | 프로비오드룩 아게 | 글루타미닐 사이클라제(ｑｃ, ｅｃ 2.3.2.5)의 헤테로사이클릭 억제제 |
| EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
| CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| ES2663680T3 (es) | 2012-12-13 | 2018-04-16 | H. Lundbeck A/S | Composiciones que comprenden vortioxetina y donepezilo |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
| US10537552B2 (en) | 2015-05-05 | 2020-01-21 | Carafe Drug Innovation, Llc | Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers |
| NZ738682A (en) | 2015-05-22 | 2022-01-28 | Agenebio Inc | Extended release pharmaceutical compositions of levetiracetam |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994472A (en) * | 1989-08-02 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
| US5296488A (en) * | 1989-08-02 | 1994-03-22 | Hoechst-Roussel Pharmaceuticals Inc. | Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
-
1997
- 1997-03-07 BR BR9708655A patent/BR9708655A/pt not_active Application Discontinuation
- 1997-03-07 JP JP53708497A patent/JP4109718B2/ja not_active Expired - Fee Related
- 1997-03-07 AT AT97908942T patent/ATE207483T1/de not_active IP Right Cessation
- 1997-03-07 WO PCT/US1997/003598 patent/WO1997038993A1/en active IP Right Grant
- 1997-03-07 HU HU9903473A patent/HUP9903473A3/hu unknown
- 1997-03-07 ES ES97908942T patent/ES2165586T3/es not_active Expired - Lifetime
- 1997-03-07 IL IL12630897A patent/IL126308A0/xx unknown
- 1997-03-07 CA CA002252039A patent/CA2252039C/en not_active Expired - Fee Related
- 1997-03-07 CN CN97193728A patent/CN1215399A/zh active Pending
- 1997-03-07 EP EP97908942A patent/EP0892796B1/en not_active Expired - Lifetime
- 1997-03-07 DE DE69707659T patent/DE69707659T2/de not_active Expired - Fee Related
- 1997-03-07 DK DK97908942T patent/DK0892796T3/da active
- 1997-03-07 PT PT97908942T patent/PT892796E/pt unknown
- 1997-04-07 TW TW086104363A patent/TW426678B/zh active
- 1997-04-08 ZA ZA9702990A patent/ZA972990B/xx unknown
- 1997-04-11 AR ARP970101447A patent/AR006606A1/es unknown
-
1998
- 1998-10-09 NO NO984740A patent/NO984740D0/no unknown
- 1998-10-12 KR KR1019980708105A patent/KR20000005379A/ko active IP Right Grant
-
2001
- 2001-10-25 GR GR20010401584T patent/GR3037006T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1215399A (zh) | 1999-04-28 |
| ES2165586T3 (es) | 2002-03-16 |
| JP4109718B2 (ja) | 2008-07-02 |
| NO984740L (no) | 1998-10-09 |
| DK0892796T3 (da) | 2001-11-19 |
| CA2252039C (en) | 2002-12-24 |
| WO1997038993A1 (en) | 1997-10-23 |
| KR20000005379A (en) | 2000-01-25 |
| AU2072597A (en) | 1997-11-07 |
| CA2252039A1 (en) | 1997-10-23 |
| PT892796E (pt) | 2002-03-28 |
| EP0892796A1 (en) | 1999-01-27 |
| JP2001508400A (ja) | 2001-06-26 |
| AU716997B2 (en) | 2000-03-16 |
| AR006606A1 (es) | 1999-09-08 |
| IL126308A0 (en) | 1999-05-09 |
| GR3037006T3 (en) | 2002-01-31 |
| HUP9903473A3 (en) | 2000-09-28 |
| HUP9903473A2 (hu) | 2000-05-28 |
| EP0892796B1 (en) | 2001-10-24 |
| NO984740D0 (no) | 1998-10-09 |
| ATE207483T1 (de) | 2001-11-15 |
| DE69707659T2 (de) | 2002-05-08 |
| DE69707659D1 (de) | 2001-11-29 |
| BR9708655A (pt) | 1999-08-03 |
| TW426678B (en) | 2001-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA972990B (en) | Isatin derivatives as acetylcholinesterase inhibitors and analgesics. | |
| ZA9711376B (en) | Indole or dihydroindole derivatives | |
| PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
| GB9607729D0 (en) | Quinazoline derivatives | |
| FI956074A0 (fi) | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia | |
| GB9708655D0 (en) | Security devices | |
| ZA977326B (en) | Tetrahydroquinoline derivatives | |
| PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
| IL120488A (en) | Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions | |
| AUPO242896A0 (en) | Security device | |
| SI0892796T1 (en) | Isatin derivatives as acetylcholinesterase inhibitors and analgesics | |
| GB9616563D0 (en) | Compounds and methods | |
| AU3779997A (en) | Security device | |
| ZA97672B (en) | Tetrahydroisoquinoline derivatives. | |
| GB2312920B (en) | Security devices | |
| EP0934345A4 (en) | CONNECTIONS AND PROCEDURE | |
| GB9613375D0 (en) | Security bracket | |
| AU3315797A (en) | Security device | |
| AU3870197A (en) | Security device | |
| AU7065596A (en) | Decorative security device | |
| ZA978046B (en) | Compounds and methods. | |
| AUPN939796A0 (en) | Baccarat-double-triple ties | |
| GB9619255D0 (en) | Security arrangements | |
| ZA978998B (en) | Indole derivatives. | |
| GB9623742D0 (en) | Inhibitors |